Magle Chemoswed Holding Ab
Magle Chemoswed Holding AB (publ), together with its subsidiaries, engages in research and development of pharmaceutical and medical device products in Sweden. It provides warfarin sodium products used as anticoagulants for multiple indications; melperone hydrochloride, which is an antipsychotic agent; isradipine, a calcium channel blocker used to treat hypertension; and benserazide hydrochloride… Read more
Magle Chemoswed Holding Ab (MAGLE) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.092x
Based on the latest financial reports, Magle Chemoswed Holding Ab (MAGLE) has a cash flow conversion efficiency ratio of -0.092x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-48.89 Million) by net assets (Skr531.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Magle Chemoswed Holding Ab - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Magle Chemoswed Holding Ab's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Magle Chemoswed Holding Ab Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Magle Chemoswed Holding Ab ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Logistic Properties of the Americas
NYSE MKT:LPA
|
0.019x |
|
Ebusco Holding N.V.
F:8J30
|
N/A |
|
Ashima Limited
NSE:ASHIMASYN
|
0.004x |
|
Skandia Greenpower AS
OL:SKAND
|
0.220x |
|
Ingram Micro Bilisim Sistemleri A.S.
IS:INGRM
|
0.002x |
|
PESTECH International Bhd
KLSE:5219
|
-0.177x |
|
MCKESSON
MU:MCK
|
-0.795x |
|
Brooks Laboratories Limited
NSE:BROOKS
|
0.003x |
Annual Cash Flow Conversion Efficiency for Magle Chemoswed Holding Ab (2017–2024)
The table below shows the annual cash flow conversion efficiency of Magle Chemoswed Holding Ab from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr560.60 Million | Skr-11.70 Million | -0.021x | -121.54% |
| 2023-12-31 | Skr158.22 Million | Skr15.33 Million | 0.097x | +14.08% |
| 2022-12-31 | Skr146.77 Million | Skr12.47 Million | 0.085x | -54.73% |
| 2021-12-31 | Skr138.79 Million | Skr26.04 Million | 0.188x | +492.89% |
| 2020-12-31 | Skr116.12 Million | Skr-5.54 Million | -0.048x | +23.40% |
| 2019-12-31 | Skr113.66 Million | Skr-7.08 Million | -0.062x | -128.56% |
| 2018-12-31 | Skr50.67 Million | Skr11.06 Million | 0.218x | -65.21% |
| 2017-12-31 | Skr42.98 Million | Skr26.96 Million | 0.627x | -- |